Ignacio Faus
Vermögen: 12 400 $ am 31.05.2026
Vermögen: 12 400 $ am 31.05.2026
Ignacio Faus was the founder of Palau Pharma SA, serving as Chief Executive Officer from 2006 to 2013.
Dr. Faus is the founder of NFL Biosciences SAS, holding the title of Director & Managing Director since 2024.
Dr. Faus is the founder of DRI Healthcare, serving as Advisor.
Former positions include Chief Executive Officer at Mologen AG from 2018 to 2019, Chief Executive Officer & Director at Genmedica Therapeutics SL, Executive Director at Sage Healthcare Ltd., and Manager-Business Development at Noucor Health SA from 1993 to 2006.
Education includes a doctorate from Indiana University conferred in 1998 and an MBA from Kellogg School of Management conferred in 1993.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DRI Healthcare Trust
DRI Healthcare Trust Investment Trusts/Mutual FundsMiscellaneous Operates as a royalty trust 0 % | 13.11.2025 | 1.000 ( 0 % ) | 12 400 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NFL BIOSCIENCES | Direktor/Vorstandsmitglied | 17.10.2024 |
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Berater | - |
| Unternehmen | Position | Ende |
|---|---|---|
| MOLOGEN AG | Vorstandsvorsitzender | 31.03.2019 |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Provides research and development services to the pharmaceutical sector | Vorstandsvorsitzender | 01.01.2013 |
Noucor Health SA
Noucor Health SA Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufacturing of medicines & food supplements | Corporate Officer/Principal | 01.11.2006 |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services to the healthcare industry | Direktor/Vorstandsmitglied | - |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
DRI Healthcare
DRI Healthcare Investment ManagersFinance DRI Healthcare invests in royalty interests in leading pharmaceutical and biotechnology companies, research institutions, universities and inventors. | Finance |
MOLOGEN AG
MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noucor Health SA
Noucor Health SA Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufacturing of medicines & food supplements | Commercial Services |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Health Technology |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Provides research and development services to the pharmaceutical sector | Health Technology |
Sage Healthcare Ltd.
Sage Healthcare Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services to the healthcare industry | Commercial Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NFL Biosciences SAS
NFL Biosciences SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops botanical treatments for addictions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen